布拉氏酵母菌散联合苯巴比妥治疗新生儿黄疸的疗效分析

Analysis of curative effect of yeast burra powder combined with phenobarbital in the treatment of neonatal jaundice

目的:探讨苯巴比妥联合布拉氏酵母菌散治疗新生儿黄疸的临床疗效。方法:回顾性收集本院2020年2月至2022年6月期间收治的70例新生儿黄疸患儿的临床资料,根据治疗方法的不同分为对照组(使用苯巴比妥治疗)和观察组(使用苯巴比妥联合布拉氏酵母菌散治疗)。分析对比两组的临床疗效,康复情况及不良反应。结果:观察组的临床治疗总有效率显著高于对照组(P<0.05)。观察组的光疗时间、黄疸消退时间、胆红素下降至正常值时间、住院时间均显著短于对照组(P<0.05)。两组的不良反应发生率无显著差异(P>0.05)。结论:苯巴比妥联合布拉氏酵母菌散治疗新生儿黄疸,能促进患儿康复,降低患儿胆红素水平,提升疗效,且较为安全可靠。

Objective:To investigate the clinical efficacy of phenobarbital combined with yeast burra powder in the treatment of neonatal jaundice.Methods:The clinical data of 70 children with neonatal jaundice admitted to our hospital from February 2020 to June 2022 were retrospectively collected,and were divided into control group(treated with phenobarbital)and observation group(treated with phenobarbital combined with yeast powder)according to different treatment methods.The clinical efficacy,rehabilitation and adverse reactions of the two groups were analyzed and compared.Results:The total effective rate of observation group was significantly higher than that of control group(P<0.05).The time of phototherapy,the time of jaundice resolution,the time of bilirubin decline to normal value and the length of hospital stay in the observation group were significantly shorter than those in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Phenobarbital combined with yeast burra powder in the treatment of neonatal jaundice can promote the recovery of children,reduce the level of bilirubin,improve the efficacy,and is safe and reliable.